辉瑞终于倾听CFC,给儿童做低剂量实验

billwanhua

本站元老
注册
2005-07-07
消息
16,729
荣誉分数
5,491
声望点数
373

Last week, Pfizer released details of a Phase 2/3 trial that showed its Covid-19 vaccine was safe and generated a "robust" antibody response in children 5-11. The trial included 2,268 5- to-11-year-olds and used a two-dose regimen of the vaccine administered 21 days apart. This trial used a 10-microgram dose -- smaller than the 30-microgram dose given to those 12 and older.

圈哥功劳不小 :evil:


 
哈哈,谦虚一句,

信圈儿哥得永生!:evil:
 

In a statement on Wednesday, the company said the booster shot, using a reduced dose of 50 micrograms that is half the dose used in the existing vaccine, raised antibody levels against the delta variant by more than 40-fold in a clinical trial.
Moderna 也第三针把100 mg 改成50 mg,浓度太高吃不消
 

In a statement on Wednesday, the company said the booster shot, using a reduced dose of 50 micrograms that is half the dose used in the existing vaccine, raised antibody levels against the delta variant by more than 40-fold in a clinical trial.
Moderna 也第三针把100 mg 改成50 mg,浓度太高吃不消

可能给第四针留了些余量。。。。

利润还提高一倍。
 
后退
顶部